Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000622864 | SCV000742719 | pathogenic | Inborn genetic diseases | 2017-07-03 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000671085 | SCV000796027 | pathogenic | DE SANCTIS-CACCHIONE SYNDROME; Cerebrooculofacioskeletal syndrome 1; Cockayne syndrome type 2 | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733375 | SCV000861440 | pathogenic | not provided | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000784896 | SCV000923433 | pathogenic | Cockayne syndrome type 2 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000733375 | SCV001219828 | pathogenic | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1288*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (rs185142838, gnomAD 0.1%). This premature translational stop signal has been observed in individuals with clinical features of Cockayne and Cerebrooculofacioskeletal syndrome (PMID: 19894250, 20456449, 29572252). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 31578). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000024284 | SCV001522601 | pathogenic | Cerebrooculofacioskeletal syndrome 1 | 2020-06-09 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000733375 | SCV003918492 | pathogenic | not provided | 2022-10-10 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 19894250, 32453336, 29572252, 27004399, 23311583, 20456449) |
OMIM | RCV000024284 | SCV000045575 | pathogenic | Cerebrooculofacioskeletal syndrome 1 | 2010-12-01 | no assertion criteria provided | literature only | |
Service de Génétique Moléculaire, |
RCV000784896 | SCV001432393 | pathogenic | Cockayne syndrome type 2 | no assertion criteria provided | clinical testing |